Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • Index of Technical Documentation or Product File
    • Summary of Technical Documentation (STED)
    • Description and specifications
    • R-TF-001-007 Declaration of conformity
    • GSPR
    • Clinical
      • Evaluation
      • Investigation
        • 馃梽 Drafts
        • R-015-005 Investigator's Brochure Legit.Health_acne
        • AIHS4 2025
        • BI 2024
          • R-TF-015-004 Clinical investigation plan
          • R-TF-015-006 Clinical investigation report
          • R-TF-015-010 Annex E ISO 14155
        • COVIDX EVCDAO 2022
        • DAO Derivaci贸n O 2022
        • DAO Derivaci贸n PH 2022
        • IDEI 2023
        • MC EVCDAO 2019
        • PH 2024
        • SAN 2024
      • R-TF-015-008 Clinical development plan
    • Design and development
    • Design History File
    • IFU and label
    • Post-Market Surveillance
    • Quality control
    • Risk Management
    • Usability and Human Factors Engineering
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • External documentation
  • Legit.Health Plus Version 1.1.0.0
  • Clinical
  • Investigation
  • BI 2024
  • R-TF-015-010 Annex E ISO 14155

R-TF-015-010 Annex E ISO 14155

Document TitlePurposeIncludedJustification if not provided
Investigator's BrochureProvides clinical and non-clinical data on the investigational device relevant to its study in human subjects.FALSEIn this study, the development of an Investigator's Brochure is not considered necessary, as the research is an observational, retrospective study based solely on the review of previously collected patient images. At no point did the study involve direct contact with patients, nor did it alter their clinical care or treatment plans.
Clinical Investigation Plan (CIP)Describes the rationale, objectives, design, methodology, monitoring, and conduct of the clinical investigation.TRUE
Subject Information Sheet and Informed Consent Form (ICF)Ensures that potential study subjects are adequately informed about the investigation and provide voluntary consent.FALSEThe requirement for a Subject Information Sheet and Informed Consent Form (ICF) is waived due to the retrospective, non-interventional nature of the research. The study involved the review of anonymized clinical images that had been previously collected as part of routine medical care, with no additional data collection, patient contact, or interventions taking place.
Ethics Committee ApprovalOfficial approval from the ethics committee to conduct the clinical investigation.FALSEThis study does not require Ethics Committee approval because it involves the retrospective analysis of fully anonymized clinical images that were originally collected during routine medical care. The research did not involve the recruitment of patients, any form of intervention, or changes to standard clinical practice.
Regulatory Authority AuthorizationAuthorization or notification from relevant regulatory bodies to proceed with the clinical investigation.FALSEThis study did not require Regulatory Authority Authorization, as it involved only the retrospective analysis of fully anonymized clinical images originally collected during routine clinical care. According to applicable Spanish legislation, such observational and non-interventional studies are exempt from regulatory authorization requirements. Additionally, the study was designed in consideration of ISO 14155 principles and MDR Annex XV provisions.
Case Report Forms (CRFs)Documents designed to record all protocol-required information to be reported to the sponsor on each trial subject.TRUEIn the present clinical investigation, the Case Report Form (CRF) was implemented through a secure web-based system designed for the standardized annotation of study images. Data generated through investigator annotations were systematically captured, securely stored, and are available for export in CSV file format. The complete dataset, containing the original investigator annotations, can be provided upon formal request to the Sponsor. Full traceability from source data to exported records is maintained in accordance with Good Clinical Practice (GCP) and applicable regulatory requirements.
Monitoring PlanDescribes the strategy, methods, responsibilities, and requirements for monitoring the clinical investigation.TRUEDetailed in the CIP
Subject Recruitment MaterialsMaterials used to recruit subjects, ensuring they are ethically and appropriately informed.FALSEThis study is exempt from the requirement to provide Subject Recruitment Materials because it involves only the retrospective analysis of fully anonymized clinical images collected during routine medical care. No active recruitment, advertisement, or solicitation of participants was conducted for the purposes of this study. As there was no direct contact with subjects, and no new data collection from them was performed, recruitment materials were not necessary nor applicable. This approach is in alignment with ISO 14155 and relevant regulatory guidelines for retrospective, non-interventional studies.
Signed AgreementsContracts between the sponsor, investigators, and institutions detailing roles and responsibilities.TRUEAccessible upon formal request addressed to the study sponsor.
Delegation of Duties LogDocuments identifying the study-related duties and responsibilities assigned to each team member.TRUEDetailed in the CIP
Training RecordsEvidence of training provided to the investigation team on the CIP, investigational device, and GCP principles.TRUETraining sessions were conducted for all investigators and study staff involved in the clinical investigation. The content of the training included the study protocol, the correct use of the device, data entry procedures, and compliance with ISO 14155 and Good Clinical Practice (GCP) requirements. Attendance logs were maintained, and the training records are available in presentation format (slides) detailing the topics covered. These presentations, along with participant attendance records, are retained as part of the study's essential documents and can be provided for audit or inspection upon request.
Investigational Device Accountability RecordsTracks the receipt, use, and disposition of the investigational device to ensure traceability.FALSEGiven the software nature of the medical device, the research team was granted controlled access to the Legit.Health annotation platform through individualized login credentials (username and password). This method ensured proper access and traceability of all annotation activities. If required, the corresponding email communications confirming access provision can be shared to further support documentation and traceability.
Subject Identification Code ListConfidential list linking subjects' codes to their identities, maintained by the investigator.FALSEThis study involves the retrospective analysis of fully anonymized clinical images that were originally collected during routine medical care. The research did not involve the recruitment of patients, any form of intervention, or changes to standard clinical practice.
Screening and Enrollment LogsDocuments tracking the screening and enrollment status of potential and actual study subjects.FALSEThis study involves the retrospective analysis of fully anonymized clinical images that were originally collected during routine medical care. The research did not involve the recruitment of patients, any form of intervention, or changes to standard clinical practice.
Investigational Device Dossier (IDD)Comprehensive technical and clinical data on the investigational device, including design, manufacturing, and performance information.TRUETraining records in this case served the same purpose.
Insurance StatementProof of insurance coverage for participants in case of study-related injuries.FALSEIt was not required for this study, as it involved only the retrospective analysis of fully anonymized clinical images collected during routine medical care. No interventions, procedures, or actions involving risk to participants were performed.
Financial Disclosure RecordsDocumentation of any financial interests of investigators that could affect the study's integrity.TRUE
Audit CertificatesReports from independent audits assessing compliance with the CIP and GCP.FALSENo audit has been carried out for CIP and GCP compliance
Final Clinical Investigation ReportA comprehensive report summarizing the clinical investigation's methodology and results.TRUE

Signature meaning

The signatures for the approval process of this document can be found in the verified commits at the repository for the QMS. As a reference, the team members who are expected to participate in this document and their roles in the approval process, as defined in Annex I Responsibility Matrix of the GP-001, are:

  • Author: Team members involved
  • Reviewer: JD-003, JD-004
  • Approver: JD-005
Previous
R-TF-015-006 Clinical investigation report
Next
COVIDX EVCDAO 2022
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)